Analysts expect NanoString Technologies Inc (NASDAQ:NSTG) to announce ($0.60) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for NanoString Technologies’ earnings, with estimates ranging from ($0.71) to ($0.51). NanoString Technologies posted earnings of ($0.45) per share in the same quarter last year, which suggests a negative year over year growth rate of 33.3%. The company is scheduled to report its next earnings report on Thursday, November 1st.

On average, analysts expect that NanoString Technologies will report full year earnings of ($2.61) per share for the current year, with EPS estimates ranging from ($2.76) to ($2.50). For the next fiscal year, analysts anticipate that the company will report earnings of ($2.11) per share, with EPS estimates ranging from ($2.71) to ($1.60). Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that cover NanoString Technologies.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings results on Tuesday, August 7th. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.71) by ($0.09). The firm had revenue of $25.00 million for the quarter, compared to analyst estimates of $25.10 million. NanoString Technologies had a negative return on equity of 201.90% and a negative net margin of 54.34%.

NSTG has been the subject of a number of recent analyst reports. Zacks Investment Research downgraded shares of NanoString Technologies from a “hold” rating to a “sell” rating in a report on Wednesday, June 6th. Robert W. Baird raised their price target on shares of NanoString Technologies from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Monday, June 4th. ValuEngine upgraded shares of NanoString Technologies from a “sell” rating to a “hold” rating in a report on Friday, August 3rd. Morgan Stanley raised their price target on shares of NanoString Technologies from $12.00 to $16.00 and gave the stock an “equal weight” rating in a report on Friday, July 13th. Finally, BidaskClub downgraded shares of NanoString Technologies from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 15th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. NanoString Technologies presently has a consensus rating of “Buy” and an average price target of $17.60.

In other news, Director Nicholas Galakatos sold 85,823 shares of the firm’s stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $15.99, for a total transaction of $1,372,309.77. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 20.90% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in NSTG. Metropolitan Life Insurance Co. NY acquired a new stake in NanoString Technologies in the 2nd quarter valued at approximately $108,000. MetLife Investment Advisors LLC acquired a new stake in NanoString Technologies in the 2nd quarter valued at approximately $155,000. Engineers Gate Manager LP acquired a new stake in NanoString Technologies in the 2nd quarter valued at approximately $261,000. GSA Capital Partners LLP acquired a new stake in NanoString Technologies in the 2nd quarter valued at approximately $271,000. Finally, Acadian Asset Management LLC acquired a new stake in NanoString Technologies in the 2nd quarter valued at approximately $325,000. Institutional investors and hedge funds own 73.34% of the company’s stock.

Shares of NASDAQ NSTG opened at $18.02 on Friday. The company has a market cap of $498.65 million, a PE ratio of -9.79 and a beta of 0.63. The company has a debt-to-equity ratio of 5.77, a current ratio of 2.49 and a quick ratio of 2.01. NanoString Technologies has a 1 year low of $5.87 and a 1 year high of $18.86.

About NanoString Technologies

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Recommended Story: How do investors use RSI to grade stocks?

Get a free copy of the Zacks research report on NanoString Technologies (NSTG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.